Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$5.75 USD
-0.18 (-3.04%)
Updated May 8, 2024 04:00 PM ET
After-Market: $5.74 -0.01 (-0.17%) 6:32 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.15 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | -33.33% |
ABR | 1.22 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.68 |
Next Year | -0.68 |
EPS (TTM) | -1.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.73M | 18.28M | 70.91M | 92.74M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 17.00M | 20.00M | 76.30M | 116.18M |
Low Estimate | 16.30M | 17.50M | 67.50M | 78.74M |
Year ago Sales | 15.19M | 15.08M | 58.44M | 70.91M |
Year over Year Growth Est. | 10.15% | 21.23% | 21.33% | 30.79% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.15 | -0.14 | -0.68 | -0.68 |
# of Estimates | 3 | 3 | 5 | 4 |
Most Recent Consensus | -0.16 | -0.13 | -0.51 | -0.35 |
High Estimate | -0.13 | -0.12 | -0.51 | -0.35 |
Low Estimate | -0.17 | -0.15 | -0.95 | -1.00 |
Year ago EPS | -0.27 | -0.51 | -1.02 | -0.68 |
Year over Year Growth Est. | 44.44% | 72.55% | 33.33% | -0.29% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.15 | -0.14 | -0.68 | -0.68 |
7 Days Ago | -0.15 | -0.14 | -0.68 | -0.68 |
30 Days Ago | -0.15 | -0.14 | -0.68 | -0.68 |
60 Days Ago | -0.16 | -0.16 | -0.79 | -0.69 |
90 Days Ago | -0.23 | -0.21 | -0.97 | -0.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | -0.14 | -0.68 | -0.68 |
Zacks Consensus Estimate | -0.15 | -0.14 | -0.68 | -0.68 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.28 | -0.51 | -0.27 | NA |
Estimate | -0.18 | -0.28 | -0.27 | -0.29 | NA |
Difference | -0.06 | 0.00 | -0.24 | 0.02 | -0.07 |
Surprise | -33.33% | 0.00% | -88.89% | 6.90% | -28.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more